Nubeqa (darolutamide)

pCPA File Number: 21244
Negotiation Status:
Active Negotiation
Indication(s):
non-metastatic castrate resistant prostate cancer
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
pCODR 10196
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable